Physician

Abiola Falilat Ibraheem, M.B.CHB

According to 2025 Medicare claims, Abiola Ibraheem, M.B.CHB (NPI: 1013273614) practices hematology/oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (NPI: 1609094739; TIN: 376000511) and primary practice location at 60612-7232. Ibraheem is affiliated with the UCMCNACO, LLC (ACO ID: A3531) and Sound Physicians Long Term Care Management, LLC (ACO ID: A5220), participating under the MSSP model.

Ibraheem's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 39 traditional Medicare patients, billed 186 HCPCS/CPT codes, and received $17,292 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 125 prescription claims across 25 beneficiaries totaling $255,423 in drug costs, led by Verzenio (Abemaciclib). Open Payments data shows 10 records totaling $45,352. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $8,932 to $17,292. Similarly, Part D prescription costs have risen steadily, from $9,339 to $255,423. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$8.6K$17K2019 Medicare payment: $8,932 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $6,285 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $7,691 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $16,900 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $8,406 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $17,292 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20195261$8,932
20204750$6,285
20214749$7,691
202244177$16,900
20232083$8,406
202439186$17,292

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$128K$255K2015 Drug cost: $9,339 (USD; Tot_Drug_Cst)2016 Drug cost: $2,294 (USD; Tot_Drug_Cst)2017 Drug cost: $36,013 (USD; Tot_Drug_Cst)2018 Drug cost: $197 (USD; Tot_Drug_Cst)2022 Drug cost: $45,542 (USD; Tot_Drug_Cst)2023 Drug cost: $253,234 (USD; Tot_Drug_Cst)2024 Drug cost: $255,423 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151755$9,339
20161436$2,294
20171543$36,013
2018N/R13$197
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20222258$45,542
20231774$253,234
202425125$255,423

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes1721$137
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes1213$108
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes1773$98
99239Hospital discharge day management, more than 30 minutes2025$94

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VerzenioAbemaciclib18504$251,061
AnastrozoleAnastrozole622,810$782

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$645AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.2$44,708BOARD OF TRUSTEES OF THE UNIVERSITY
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abiola Falilat Ibraheem, M.B.CHB?

Tedicare shows public-source Medicare data for Abiola Falilat Ibraheem, M.B.CHB (NPI 1013273614), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abiola Falilat Ibraheem, M.B.CHB have ACO affiliation data?

Abiola Falilat Ibraheem, M.B.CHB is shown with ACO affiliation data for UCMCNACO, LLC (MSSP, ACO ID A3531) and Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220).

What billing organization is linked to Abiola Falilat Ibraheem, M.B.CHB?

Abiola Falilat Ibraheem, M.B.CHB is linked to THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (billing NPI 1609094739) in the available physician profile data.

Does Abiola Falilat Ibraheem, M.B.CHB have Open Payments data?

Abiola Falilat Ibraheem, M.B.CHB has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.